Associate Professor Brendon Neuen
Senior Research Fellow, Renal and Metabolic Nephrologist and Director, Kidney Trials, Royal North Shore Hospital Clinical Associate Professor, University of Sydney Conjoint Associate Professor, UNSW Sydney
Ph.D. MBBS(Hons) MSc(Oxon) FRACP FASN
Associate Professor Brendon Neuen is a Staff Specialist Nephrologist and Director of Kidney Trials at Royal North Shore Hospital and Senior Research Fellow at The George Institute for Global Health. He graduated in medicine at James Cook University with 1st Class Honours and an Academic Medal; completed a Masters in Global Health and Epidemiology from the University of Oxford; a PhD from the University of New South Wales; and a Postdoctoral Fellowship at Brigham and Women's Hospital, Harvard Medical School. He is a Fellow of the Royal Australasian College of Physicians and a Fellow of the American Society of Nephrology.
He is an internationally recognised expert on cardio-kidney-metabolic health and serves as the founding Secretariat of the SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium (Smart C), which brings together data from over 90,000 patients from large-scale randomized trials to better understand the effects of this class of medicine in major patient groups. In addition, A/Prof Neuen is involved in the leadership of multiple ongoing international multi-centre randomized trials evaluating treatments to prevent kidney failure, cardiovascular events, or both. His work has directly informed more than 25 major international and national clinical practice guidelines, position papers and scientific statements which define best practice for the care of people with chronic kidney disease, including the Kidney Disease Improving Global Outcomes (KDIGO) Guidelines and the American Diabetes Association (ADA) Standards of Care.
A/Prof Neuen is the author of over 100 peer-reviewed publications in general medical journals including The Lancet, BMJ and Nature Medicine, and specialty journals including Lancet Diabetes and Endocrinology, Circulation, and the Journal of the American Society of Nephrology. He serves on the Editorial Boards of the American Society of Nephrology and Nephrology Dialysis and Transplantation (flagship journal of the European Renal Association). His work is supported by the National Health and Medical Research Council of Australia, Ramaciotti Foundation as well as philanthropic sources, and has been recognised through multiple awards, including the Royal Society of New South Wales Ida Browne Medal, and the American Heart Association's Paul Dudley White International Scholar Award.
